Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension [Phase 3]
This clinical trial update reports the completion of a Phase 3 safety study extension for Iloprost Power 15 in pulmonary arterial hypertensi…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Iloprost Power 15 in Pulmonary Arterial Hypertension [Phase 3]
Phase 3 clinical trial of Iloprost Power 15 for pulmonary arterial hypertension has completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension [NA]
A Laval University–led clinical trial evaluating the responsiveness of exercise tests in pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Epoprostenol for Injection in Pulmonary Arterial Hypertension [Phase 4]
Phase 4 trial update for Epoprostenol for Injection in pulmonary arterial hypertension. The study has completed and results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401 [Phase 4]
Phase 4 extension study of Epoprostenol for Injection in pulmonary arterial hypertension with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH) [Phase 4]
This Phase 4 clinical trial evaluating the combination of bosentan and inhaled iloprost for idiopathic pulmonary arterial hypertension has b…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1) [Phase 4]
Phase 4 ATHENA-1 evaluated adding ambrisentan to background PDE5 inhibitor therapy in pulmonary arterial hypertension; results were posted i…
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension [Phase 2]
Phase 2 study of ambrisentan for liver function test rescue in pulmonary arterial hypertension has completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
Pilot chart review study of sitaxentan in patients with pulmonary arterial hypertension has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients [Phase 3]
A Phase 3 trial evaluating sildenafil for Eisenmenger-associated pulmonary arterial hypertension has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil [Phase 1]
Phase 1 pharmacokinetic study assessing the effect of renal impairment on the pharmacokinetics of oral treprostinil in pulmonary arterial hy…
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension [Phase 3]
A long-term, open-label Phase 3 safety study of sitaxsentan sodium in pulmonary arterial hypertension was terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases
This completed clinical trial from Medical University of Graz explored early recognition of pulmonary arterial hypertension in patients with…
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS) [Phase 3]
Phase 3 trial evaluating sitaxsentan for pulmonary arterial hypertension with an assessment of adding sildenafil; the study was terminated a…
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil [Phase 3]
Phase 3 trial comparing sitaxsentan plus sildenafil versus sitaxsentan alone in pulmonary arterial hypertension was terminated. Results were…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses [Phase 1]
Phase 1 pharmacokinetic drug–drug interaction study evaluating sitaxsentan with sildenafil and sitaxsentan with tadalafil in pulmonary arter…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety [Phase 3]
Phase 3 trial evaluating monotherapy and combination therapy with sitaxsentan for pulmonary arterial hypertension; study terminated with res…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers [Phase 1]
Phase 1 dose-finding, safety, and pharmacodynamic study of inhaled sodium nitrite solution in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: A Study to Evaluate GSK1325760A - a Long-Term Extension Study [Phase 3]
This clinical trial update reports the completion and posting of results for a Phase 3 long-term extension study evaluating GSK1325760A. The…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)
A Mayo Clinic-sponsored study evaluated whether lisinopril modulates the activity of sildenafil in patients with pulmonary arterial hyperten…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin
A non-interventional registry was established to collect predefined safety data from patients prescribed Thelin (treprostinil) for pulmonary…
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension [Phase 2]
This document reports results from a Phase 2 extension study of ambrisentan in pulmonary arterial hypertension, with results posted in Janua…
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: The Early Recognition of Pulmonary Arterial Hypertension [NA]
A completed clinical trial from the Medical University of Graz investigating early recognition of Pulmonary Arterial Hypertension.
-
CLINICAL_TRIALS trial_result · 2011-12-14Clinical Trial Update: Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients [Phase 3]
Phase 3 long-term open-label safety study of sitaxentan sodium in Japanese patients with pulmonary arterial hypertension was terminated; res…
-
CLINICAL_TRIALS trial_result · 2011-12-01Clinical Trial Update: A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients [Phase 3]
A Phase 3 safety and efficacy study of sitaxentan sodium in Japanese patients with pulmonary arterial hypertension was terminated; trial res…